Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence, Temporal Trends, and Surgical Shift of Achilles Tendon Rupture: A Systematic Review and Meta-analysis.

Sports medicine (Auckland, N.Z.)·2026
Same author

Mammographic Screening in the Brazilian Unified Health System.

JCO global oncology·2026
Same author

Transgenic Diffusible Signaling Factor-Producing Rootstocks Confer Resistance to <i>Xanthomonas citri</i> subsp. <i>citri</i> in Grafted Nontransgenic Scions.

Plant disease·2025
Same author

Myositis and Deep Suppurative Soft Tissue Infections Caused by Group a Streptococcus.

The Pediatric infectious disease journal·2025
Same author

Microbiome-informed study of the mechanistic basis of methane inhibition by <i>Asparagopsis taxiformis</i> in dairy cattle.

mBio·2024
Same author

Racial Disparities in Glioblastoma Genomic Alterations: A Comprehensive Analysis of a Multi-Institution Cohort of 2390 Patients.

World neurosurgery·2024

Related Experiment Video

Updated: Aug 4, 2025

Lentivirus Production
11:42

Lentivirus Production

Published on: October 2, 2009

66.1K

Process intensification for lentiviral vector manufacturing using tangential flow depth filtration.

Robert M Tona1, Reeti Shah1, Kimberly Middaugh1

  • 1Cell and Gene Therapy, GSK, 1250 S. Collegeville Road, Collegeville, PA 19426, USA.

Molecular Therapy. Methods & Clinical Development
|March 30, 2023
PubMed
Summary
This summary is machine-generated.

Process intensification using tangential flow depth filtration can increase lentiviral vector production. This method enables higher cell densities and efficient separation, potentially yielding 10,000 doses for cell and gene therapies per batch.

Keywords:
bioreactorcontinuous manufacturinglentiviral vectorsmanufacturingperfusionprocess intensificationtangential flow depth filtration

More Related Videos

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector&#45;Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.3K
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

9.0K

Related Experiment Videos

Last Updated: Aug 4, 2025

Lentivirus Production
11:42

Lentivirus Production

Published on: October 2, 2009

66.1K
Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector&#45;Mediated Gene Manipulation
06:33

Author Spotlight: Exploring Macrophage Immunometabolism Through Lentiviral Vector-Mediated Gene Manipulation

Published on: February 16, 2024

1.3K
An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector
10:13

An Efficient In Vitro Transposition Method by a Transcriptionally Regulated Sleeping Beauty System Packaged into an Integration Defective Lentiviral Vector

Published on: January 12, 2018

9.0K

Area of Science:

  • Biotechnology
  • Process Engineering
  • Gene Therapy Manufacturing

Background:

  • Gene therapies require scalable and cost-effective manufacturing of viral vectors.
  • Process intensification is a key strategy to increase viral vector yield per batch.
  • Lentiviral vectors are crucial for CAR T and TCR cell therapies.

Purpose of the Study:

  • To investigate process intensification for lentiviral vector manufacturing.
  • To evaluate tangential flow depth filtration for enabling perfusion and cell expansion.
  • To determine the potential dose output of an intensified lentiviral vector production process.

Main Methods:

  • Implemented perfusion in a production bioreactor using a stable producer cell line.
  • Utilized hollow-fiber depth filters (polypropylene, 2-4 μm channels) for tangential flow depth filtration.
  • Operated the intensified process at a 200-L scale in suspension culture.

Main Results:

  • Tangential flow depth filtration enabled perfusion, leading to expanded cell densities.
  • The depth filters demonstrated high capacity, extended functional life, and efficient separation of lentiviral vectors.
  • The intensified process is anticipated to yield approximately 10,000 doses per batch.

Conclusions:

  • Process intensification with tangential flow depth filtration is a viable strategy for increasing lentiviral vector production.
  • This approach can significantly enhance the accessibility and affordability of gene therapies.
  • The technology shows promise for meeting the large-scale demand for CAR T and TCR therapies.